Nolato ABFRA:NBF 82 FCF Yield % is 9.01 as of Jun. 30, 2026, which is 45% above its 10-year median of 6.20. GuruFocus rates FRA:NBF with a GF Score™ of 82/100 and a GF Value™ of €4.74 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Nolato AB ranks better than 92.39% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Nolato AB's FCF Yield % or its related term are showing as below:
FRA:NBF'
s FCF Yield % Range Over the Past 10 Years
Min: 2.22 Med: 6.2 Max: 11.19
Current: 9.01
During the past 13 years, the highest FCF Yield % of Nolato AB was 11.19%. The lowest was 2.22%. And the median was 6.20%.
FRA:NBF's FCF Yield % is ranked better than 92.39% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: -0.385
vs FRA:NBF: 9.01
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Nolato AB FCF Yield % Related Terms
Nolato AB FCF Yield % Historical Data
* Premium members only.
The historical data trend for Nolato AB's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nolato AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nolato AB FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nolato AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Nolato AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nolato AB (FRA:NBF) has a FCF Yield % of 9.01 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nolato AB and its competitors. This is 45% above median its historical median of 6.20. Over the past decade, Nolato AB's FCF Yield % has ranged from 2.22 to 11.19. According to the industry distribution chart, Nolato AB ranks #65 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 7.6%.
Is Nolato AB's FCF Yield % too high?
Nolato AB's current FCF Yield % of 9.01 is 45% above median its 10-year median of 6.20. Over the past 10 years, this metric has ranged from a low of 2.22 to a high of 11.19. Based on the distribution chart, Nolato AB ranks #65 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nolato AB has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nolato AB ranks #65 out of 854 companies for FCF Yield %. This places Nolato AB in the top 8% of its industry — outperforming the majority of peers. Historically, Nolato AB's own FCF Yield % has ranged from 2.22 to 11.19 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nolato AB and its competitors. Nolato AB's current FCF Yield % is 9.01, which is 45% above median its own 10-year median of 6.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Based on GuruFocus' analysis, Nolato AB (FRA:NBF) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.74, compared to a current price of €4.28 — trading 9.8% below its estimated fair value. The current FCF Yield % is 9.01, which is 45% above median its 10-year median of 6.20. Nolato AB's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Nolato AB (FRA:NBF), the current FCF Yield % is 9.01 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nolato AB (FRA:NBF) Overvalued in 2026?
Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued.
The current stock price of €4.28 is trading 9.8% below its estimated GF Value™ of €4.74.
GuruFocus considers Nolato AB to be Modestly Undervalued.
Key valuation signals for FRA:NBF:
FCF Yield %: 9.01 (45% above median its 10-year median of 6.20)
GF Value™: €4.74 vs. price of €4.28 (9.8% below fair value)
No single metric tells the full story. See the FRA:NBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
82GF Score
Get the complete analysis for FRA:NBF
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NBF has been successfully added to your 
